Federation des caisses Desjardins du Quebec’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101M Buy
109,969
+11,796
+12% +$12M 0.36% 51
2025
Q4
$105M Buy
98,173
+13,233
+16% +$12.7M 0.4% 48
2025
Q3
$64.8M Buy
84,940
+5,072
+6% +$3.77M 0.26% 64
2025
Q2
$62.3M Buy
79,868
+7,056
+10% +$5.48M 0.27% 59
2025
Q1
$60.1M Buy
72,812
+16,645
+30% +$13.9M 0.3% 60
2024
Q4
$43.4M Buy
56,167
+23,452
+72% +$19.4M 0.22% 79
2024
Q3
$29M Sell
32,715
-3,740
-10% -$3.36M 0.14% 121
2024
Q2
$33M Buy
36,455
+13,036
+56% +$10.4M 0.18% 106
2024
Q1
$17.4M Buy
23,419
+9,967
+74% +$7.09M 0.13% 154
2023
Q4
$7.84M Sell
13,452
-2,768
-17% -$1.62M 0.07% 203
2023
Q3
$8.71M Sell
16,220
-1,417
-8% -$730K 0.09% 189
2023
Q2
$8.27M Sell
17,637
-609
-3% -$255K 0.08% 199
2023
Q1
$6.27M Buy
18,246
+2,265
+14% +$764K 0.07% 216
2022
Q4
$5.85M Sell
15,981
-178
-1% -$63.1K 0.07% 211
2022
Q3
$5.23M Buy
16,159
+1,581
+11% +$501K 0.06% 233
2022
Q2
$4.73M Buy
14,578
+117
+0.8% +$35.1K 0.05% 246
2022
Q1
$4.14M Sell
14,461
-206
-1% -$53K 0.04% 288
2021
Q4
$4.05M Sell
14,667
-189
-1% -$47.9K 0.04% 291
2021
Q3
$3.43M Buy
14,856
+1,915
+15% +$473K 0.04% 332
2021
Q2
$2.97M Sell
12,941
-6,520
-34% -$1.31M 0.03% 375
2021
Q1
$3.64M Sell
19,461
-3,205
-14% -$627K 0.04% 331
2020
Q4
$3.83M Buy
22,666
+11,731
+107% +$1.75M 0.05% 300
2020
Q3
$1.62M Sell
10,935
-15,755
-59% -$2.44M 0.02% 448
2020
Q2
$4.39M Buy
26,690
+3,028
+13% +$465K 0.07% 235
2020
Q1
$3.3M Sell
23,662
-13,158
-36% -$1.81M 0.06% 243
2019
Q4
$4.84M Buy
36,820
+180
+0.5% +$20.9K 0.07% 228
2019
Q3
$4.1M Sell
36,640
-1,078
-3% -$120K 0.06% 256
2019
Q2
$4.17M Sell
37,718
-18,006
-32% -$2.12M 0.06% 248
2019
Q1
$7.23M Sell
55,724
-6,466
-10% -$786K 0.11% 165
2018
Q4
$7.2M Sell
62,190
-1,873
-3% -$209K 0.12% 154
2018
Q3
$6.88M Sell
64,063
-2,729
-4% -$273K 0.1% 179
2018
Q2
$5.71M Sell
66,792
-230
-0.3% -$18.9K 0.09% 218
2018
Q1
$5.19M Sell
67,022
-8
-0% -$644 0.08% 217
2017
Q4
$5.65M Sell
67,030
-49,333
-42% -$4.2M 0.09% 200
2017
Q3
$9.97M Sell
116,363
-26,509
-19% -$2.17M 0.16% 122
2017
Q2
$11.8M Buy
142,872
+49,372
+53% +$4.03M 0.19% 103
2017
Q1
$7.86M Buy
+93,500
New +$7.49M 0.15% 128

Other funds holding LLY

Federation des caisses Desjardins du Quebec's LLY Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its Eli Lilly (LLY) stake by 12% in Q1 2026, buying an estimated $12M and bringing the position to 109,969 shares worth $101M. The position accounts for 0.36% of the portfolio, ranked #51.

Federation des caisses Desjardins du Quebec first reported a position in LLY in Q1 2017 and has held it in 37 quarters since. The position peaked at $105M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 109,969 shares of Eli Lilly worth $101M as of Q1 2026.
  • Federation des caisses Desjardins du Quebec bought 11,796 Eli Lilly shares in Q1 2026, an estimated $12M.
  • Eli Lilly made up 0.36% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #51 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Eli Lilly in Q1 2017 and has held it in 37 quarters since.
  • Federation des caisses Desjardins du Quebec's Eli Lilly position peaked at $105M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.